Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

NCT06486545 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Irinotecan Hydrochloride Liposome Injection；Paclitaxel For Injection (Albumin Bound)

Sponsor

Hunan Cancer Hospital